Optimizing imatinib sampling strategies through a population approach: a crucial step to model-informed precision dosing validation for point-of-care therapeutic drug monitoring
{{output}}
Background: Imatinib therapeutic drug monitoring (TDM) contributes at optimizing exposure, yet its implementation is limited by logistical constraints, including strict sampling time requirements. Model-Informed Precision Dosing ... ...
